workspace-logo

Share to your networks

Dylan Campbell

📣 ANNOUNCEMENT - TruSight Oncology Comprehensive is now US FDA approved!

Introducing the first US FDA-approved distributable comprehensive genomic profiling (CGP) in vitro diagnostic (IVD) with pan-cancer companion diagnostic (CDx) claims! This represents a major milestone for Illumina and our clinical Oncology product portfolio. Please share this exciting news and help our customers reap the benefits of a streamlined onboarding process and greater access to reimbursement with an IVD!


53 others have already shared this!

TruSight Oncology Comprehensive is now US FDA approved

LinkedIn

TruSight Oncology Comprehensive is now US FDA approved - the first distributable comprehensive genomic profiling IVD kit with pan-cancer companion diagnostic (CDx) claims! To learn more about TruSight Oncology Comprehensive: https://bit.ly/4edYeoH

247/3000
X / Twitter

TruSight Oncology Comprehensive is now US FDA approved - the first distributable comprehensive genomic profiling IVD kit with pan-cancer companion diagnostic (CDx) claims! To learn more about TruSight Oncology Comprehensive: https://bit.ly/4edYeoH

247/280